Articles tagged with “PHQ-9”
New research on NMDA antagonist side effects and discontinuation rates offers practical guidance for ketamine troche patients managing treatment-resistant depression.
New clinical data on NMDA receptor antagonist side effects and dropout rates—and what it means for ketamine troche dosing and monitoring routines.
Send corrections, provider questions, or advertising inquiries.
